In Vitro Release and In Vivo Pharmacokinetics of Praziquantel Loaded in Different Polymer Particles
Approximately 1 billion people are affected by neglected diseases around the world. Among these diseases, schistosomiasis constitutes one of the most important public health problems, being caused by <i>Schistosoma mansoni</i> and treated through the oral administration of praziquantel (...
Main Authors: | Emiliane Daher Pereira, Luciana da Silva Dutra, Thamiris Franckini Paiva, Larissa Leite de Almeida Carvalho, Helvécio Vinícius Antunes Rocha, José Carlos Pinto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Materials |
Subjects: | |
Online Access: | https://www.mdpi.com/1996-1944/16/9/3382 |
Similar Items
-
Praziquantel and Moxidectin pharmacokinetics in dogs after Helmimax administration
by: A. A. Smirnov, et al.
Published: (2023-01-01) -
Praziquantel–Clays as Accelerated Release Systems to Enhance the Low Solubility of the Drug
by: Ana Borrego-Sánchez, et al.
Published: (2020-09-01) -
Preparation and characterisation of Dextran-70 hydrogel for controlled release of praziquantel
by: Flávio dos Santos Campos, et al.
Published: (2013-03-01) -
Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of <i>Schistosoma mansoni</i> Infection
by: Omary Mashiku Minzi, et al.
Published: (2021-04-01) -
Pharmacokinetics of a novel endectoparasiticide topical formulation for cats, combining esafoxolaner, eprinomectin and praziquantel
by: Jacquot Virginie, et al.
Published: (2021-01-01)